Windlas Biotech gets EU-GMP certificate for Plant-IV at Dehradun

25 May 2022 Evaluate

Windlas Biotech has now received the certificate of European Union Good Manufacturing Practices (EU-GMP) by the National Institute of Pharmacy and Nutrition, Hungary for the Plant-IV situated at Dehradun. The company had undergone an inspection from April 11, 2022 to April 13, 2022.

Windlas Biotech is into domestic pharmaceutical formulations contract development and manufacturing business.

Windlas Biotech Share Price

802.55 9.20 (1.16%)
22-Jan-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1634.40
Dr. Reddys Lab 1217.15
Cipla 1371.55
Zydus Lifesciences 884.85
Lupin 2165.05
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×